USA flag logo/image

An Official Website of the United States Government

Tagging of Laboratory Mice with Microtransponders

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
93847
Program Year/Program:
2009 / SBIR
Agency Tracking Number:
GM087834
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
PharmaSeq, Inc.
11 Deer Park Dr. Suite 104 Monmouth Jct., NJ 08852-1923
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 2009
Title: Tagging of Laboratory Mice with Microtransponders
Agency: HHS
Contract: 1R43GM087834-01
Award Amount: $117,362.00
 

Abstract:

DESCRIPTION (provided by applicant): The purpose of the present project is to develop a new type of RFID tagging system for tracking laboratory mice. It is based on the PharmaSeq laser light-powered microtransponder. Its major advantages are its small size (500 5m x 500 5m x 100 5m), monolithic (one part) design, inertness (silica-based), and very low cost. No anesthetization of the mice will be required. The system will consist of the tag itself, the tag reader, and an insertion device. The microtranponder s will be implanted using the insertion device in the mouse's ear or tail just under the skin. To read the ID, thus identifying the animal, the operator will simply bring the ID reader to within the immediate proximity of the implanted microtransponder and the ID will be acquired automatically onto the computer workstation. The software will associate the ID of the implanted MTP from a particular mouse with data related to its role in experimental procedures and/or breeding history. The main goals are to: ( 1) Design and build the system; (2) Improve the sensitivity of the reader so that it is easier to read the IDs of microtransponders implanted under the skin. Several enhancements are planned, including integrating a more powerful laser into the reader, imp rovements to the ID detection algorithm, and optimization of the reader's pickup coil antenna; (3) Develop a microtransponder injector; (4) Configure a workstation to stabilize the wand on a flexible arm, freeing both of the operator's hands to manipulate the mouse and inject microtransponders; and (5) Conduct an initial biocompatibility study and test the system in different laboratories. Use of the system will improve the reliability of tracking of experimental subjects, lower costs, and prevent costly er rors including rework due do unreadable markings and lost labels. PUBLIC HEALTH RELEVANCE: Laboratory mice play a powerful role in basic research and a key role in mammalian genetic and biomedical research. They are universally accepted as the primary mode l for analyzing and understanding inherited human disorders. The new PharmaSeq system has the potential to greatly increase the use of RFID tags in laboratory mice, or even to lead to the general adoption of this new technology as a universal tagging syste m that can track animals from breeding through their entire useful lifetime.

Principal Investigator:

Wlodek Mandecki
7323550100
MANDECKI@PHARMASEQ.COM

Business Contact:

Wlodek Mandecki
mandecki@pharmaseq.com
Small Business Information at Submission:

PHARMASEQ, INC.
PHARMASEQ, INC. 11 DEER PARK DR, STE 104 MONMOUTH JUNCTION, NJ 08852

EIN/Tax ID: 151043993
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No